SEATTLE--(BUSINESS WIRE)--Geospiza, Inc., a leading developer of enterprise software solutions to automate genetic testing, today announced that it has completed a $3 million Series A preferred stock financing. The funds will be used to add sales and product development personnel to meet increased customer demand and expand its collaboration agreement with Applied Biosystems (NYSE:ABI).
